SecBot SecBot
8-K ·Filed Jun 3, 2026

OSUR

ORASURE TECHNOLOGIES INC
NEUTRAL
Impact 3/10
Horizonmonths Processed5mo ago SEC0001116463-26-000043
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Routine annual meeting results with no immediate trading catalyst. The board declassification over three years is a gradual governance change with no near-term impact. Monitor future equity grant activity under the expanded Stock Award Plan for potential dilution signals.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$4.17
T+0 close · Jun 3, 2026 · via day close
Latest settled
−13.67%
T+60 · $3.60
Vs SPY
−15.55%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 4 $4.17entry
  2. T+1 · 6mo ago −3.12%α −0.52% · $4.04
  3. T+5 · 5mo ago +0.48%α +3.03% · $4.19
  4. T+20 · 4mo ago +4.32%α +5.69% · $4.35
  5. T+60 · 3mo ago −13.67%α −15.55% · $3.60

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

OraSure Technologies held its 2026 Annual Meeting on June 3, 2026. Stockholders approved an amendment to the Stock Award Plan increasing authorized shares by 5,000,000 (to 6,982,477 total), and approved a Certificate of Amendment to declassify the Board of Directors over a three-year period starting at the 2027 annual meeting. Three Class II directors were elected for terms ending in 2029. These are routine governance and compensation actions with no material financial impact.

Key Facts

  • Stockholders approved an amendment and restatement of the 2000 Stock Award Plan, increasing shares authorized for grant by 5,000,000 to a total of 6,982,477 shares.
  • Stockholders approved a Certificate of Amendment to declassify the Board of Directors over three years, beginning at the 2027 annual meeting.
  • Three Class II directors were elected: John D. Bertrand, Steven K. Boyd, and Robert W. McMahon, each for a term ending in 2029.
  • Ratification of Grant Thornton LLP as independent auditor for fiscal 2026 passed with 59,891,739 votes for.
  • Advisory vote on executive compensation passed with 45,225,131 votes for.
  • As of the April 10, 2026 record date, there were 71,965,612 shares of common stock outstanding.

Financial Impact

No financial impact. The 5,000,000 share increase in the Stock Award Plan represents potential future dilution of approximately 6.9% of current outstanding shares (71,965,612), but no shares were issued in this filing.

dilution

Risk Factors

  • Potential future dilution from the 5,000,000 additional shares authorized under the Stock Award Plan.
  • No material operational or financial updates were provided in this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
75% bullish (8 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001116463-26-000043
Exhibit: exhibit31_certificateofa.htm0001116463-26-000043
Document: osur-20260603.htm0001116463-26-000043
Document: 0001116463-26-000043-index-headers.html0001116463-26-000043
Document: 0001116463-26-000043-index.html0001116463-26-000043
Document: 0001116463-26-000043.txt0001116463-26-000043

Track record

20 reports on OSUR

Performance horizon

6 of 6 bullish or bearish reports moved the stock their way by T+1. Best: +39.73% at T+60 after the Mar 13, 2026 report. 6 of 6 went positive at some point.

Filters
  1. Nov 12, 20264d ago 10-Q/A Neutral 2/10 Entry $3.62 to $3.62 Now $3.60 −0.55% · 0.00% +0.36% vs SPY
  2. Nov 9, 20267d ago Press Release Neutral 4/10 Entry $3.33 to $3.56 Now $3.60 +8.11% ▲ +6.91% +5.59% vs SPY
  3. Nov 9, 20267d ago SC 13G/A Neutral 3/10 Entry $3.53 to $3.33 Now $3.60 +1.98% ▼ −5.67% −5.30% vs SPY
  4. Nov 2, 202614d ago Press Release Neutral 2/10 Entry $3.46 to $3.53 Now $3.60 +4.20% ▲ +2.17% +1.87% vs SPY
  5. Oct 30, 202617d ago SC 13G/A Neutral 3/10 Entry $3.94 to $3.46 Now $3.60 −8.63% ▼ −12.31% −11.83% vs SPY
  6. Sep 17, 20268w ago SC 13D Bullish 6/10 Entry $3.56 to $3.69 Now $3.60 +1.12% ▲ +3.65% +2.10% vs SPY
  7. Jul 23, 202616w ago Court Ruling Neutral 3/10 Entry $3.97 to $3.96 Now $3.60 −9.32% ▼ −0.25% −0.27% vs SPY
  8. Jun 12, 202622w ago Institutional Cluster Mixed 4/10 Entry $4.18 to $4.17 Now $3.60 −13.88% ▼ −0.24% −2.00% vs SPY
  9. Jun 3, 202623w ago 8-K Neutral 3/10 Viewing Entry $4.17 to $4.04 Now $3.60 −13.67% ▼ −3.12% −0.52% vs SPY
  10. May 6, 202627w ago 8-K Bearish 6/10 Entry $3.13 to $3.06 Now $3.60 −15.02% ▲ +2.24% +3.07% vs SPY
Showing 10 of 20

US Market Status

Market Closed · Opens in 6h 36m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 3, 2026